ICD-10 PCS – Browse (Tables)

Code Title
Top Categories
3 Administration
3E Physiological Systems and Anatomical Regions
3E0 Introduction Administration, Physiological Systems and Anatomical Regions, Introduction
3E04 Central Vein
3E040 Open
3E0400 Antineoplastic
3E04002 High-dose Interleukin-2 Introduction of High-dose Interleukin-2 into Central Vein, Open Approach
3E04003 Low-dose Interleukin-2 Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach
3E04005 Other Antineoplastic Introduction of Other Antineoplastic into Central Vein, Open Approach
3E0400M Monoclonal Antibody Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach
3E0400P Clofarabine Introduction of Clofarabine into Central Vein, Open Approach
3E0401 Thrombolytic
3E04016 Recombinant Human-activated Protein C Introduction of Recombinant Human-activated Protein C into Central Vein, Open
3E04017 Other Thrombolytic Introduction of Other Thrombolytic into Central Vein, Open Approach
3E0402 Anti-infective
3E04028 Oxazolidinones Introduction of Oxazolidinones into Central Vein, Open Approach
3E04029 Other Anti-infective Introduction of Other Anti-infective into Central Vein, Open Approach
3E0403 Anti-inflammatory
3E0403Z No Qualifier Introduction of Anti-inflammatory into Central Vein, Open Approach
3E0404 Serum, Toxoid and Vaccine
3E0404Z No Qualifier Introduction of Serum, Toxoid and Vaccine into Central Vein, Open Approach
3E0406 Nutritional Substance
3E0406Z No Qualifier Introduction of Nutritional Substance into Central Vein, Open Approach
3E0407 Electrolytic and Water Balance Substance
3E0407Z No Qualifier Introduction of Electrolytic and Water Balance Substance into Central Vein, Open Approach
3E040F Intracirculatory Anesthetic
3E040FZ No Qualifier Introduction of Intracirculatory Anesthetic into Central Vein, Open Approach
3E040G Other Therapeutic Substance
3E040GC Other Substance Introduction of Other Therapeutic Substance into Central Vein, Open Approach
3E040GN Blood Brain Barrier Disruption Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Open Approach
3E040H Radioactive Substance
3E040HZ No Qualifier Introduction of Radioactive Substance into Central Vein, Open Approach
3E040K Other Diagnostic Substance
3E040KZ No Qualifier Introduction of Other Diagnostic Substance into Central Vein, Open Approach
3E040N Analgesics, Hypnotics, Sedatives
3E040NZ No Qualifier Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Open Approach
3E040P Platelet Inhibitor
3E040PZ No Qualifier Introduction of Platelet Inhibitor into Central Vein, Open Approach
3E040R Antiarrhythmic
3E040RZ No Qualifier Introduction of Antiarrhythmic into Central Vein, Open Approach
3E040T Destructive Agent
3E040TZ No Qualifier Introduction of Destructive Agent into Central Vein, Open Approach
3E040V Hormone
3E040VG Insulin Introduction of Insulin into Central Vein, Open Approach
3E040VH Human B-type Natriuretic Peptide Introduction of Human B-type Natriuretic Peptide into Central Vein, Open Approach
3E040VJ Other Hormone Introduction of Other Hormone into Central Vein, Open Approach
3E040W Immunotherapeutic
3E040WK Immunostimulator Introduction of Immunostimulator into Central Vein, Open
3E040WL Immunosuppressive Introduction of Immunosuppressive into Central Vein, Open
3E040X Vasopressor
3E040XZ No Qualifier Introduction of Vasopressor into Central Vein, Open Approach